(BF-B) Brown-Forman - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1156372096
BF-B: Whiskey, Wine, Liqueurs, Rum, Tequila, Gin, Vodka
Brown-Forman Corporation, a legacy player in the spirits industry since 1870, stands out for its stability and enduring success. The companys diversified portfolio spans whiskey, wine, and other spirits, with iconic brands like Jack Daniels and Woodford Reserve leading the charge. This diversification isnt just about breadth; its a strategic move to mitigate risk and capitalize on shifting consumer preferences in a competitive market. Investors will appreciate the balance between heritage and innovation, as the company continues to evolve while maintaining its core values.
What makes Brown-Forman particularly attractive is its global footprint, with operations in over a dozen countries. This reach isnt just about market expansion; its a testament to the companys ability to navigate complex regulatory landscapes and cultural nuances. The companys product range is equally impressive, covering everything from premium bourbons to tequilas and vodkas. This extensive lineup is more than just variety—its a hedge against market volatility, ensuring that the company remains resilient regardless of which spirits category is in vogue.
From a financial standpoint, Brown-Formans market cap of $15.7 billion underscores its stability and scale. The forward P/E ratio of 17.67 suggests that investors are confident in the companys growth prospects, likely driven by its strong brand portfolio and expanding global presence. The price-to-book ratio of 4.24 indicates that the market values the companys assets and brand equity highly, which is crucial in an industry where intangible assets like brand reputation are paramount. With a price-to-sales ratio of 3.85, the company is positioned as a premium player, reflecting its focus on high-margin products and disciplined pricing strategies.
Additional Sources for BF-B Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BF-B Stock Overview
Market Cap in USD | 16,904m |
Sector | Consumer Defensive |
Industry | Beverages - Wineries & Distilleries |
GiC Sub-Industry | Distillers & Vintners |
IPO / Inception | 1984-09-07 |
BF-B Stock Ratings
Growth 5y | -58.6% |
Fundamental | 47.6% |
Dividend | 52.0% |
Rel. Strength Industry | -39.7 |
Analysts | 3/5 |
Fair Price Momentum | 31.85 USD |
Fair Price DCF | 40.65 USD |
BF-B Dividends
Dividend Yield 12m | 1.63% |
Yield on Cost 5y | 1.22% |
Annual Growth 5y | 4.65% |
Payout Consistency | 88.9% |
BF-B Growth Ratios
Growth Correlation 3m | -80.1% |
Growth Correlation 12m | -74.6% |
Growth Correlation 5y | -66.7% |
CAGR 5y | -7.44% |
CAGR/Max DD 5y | -0.12 |
Sharpe Ratio 12m | -0.91 |
Alpha | -35.90 |
Beta | 0.04 |
Volatility | 29.43% |
Current Volume | 5472.9k |
Average Volume 20d | 3435.4k |
As of March 10, 2025, the stock is trading at USD 36.93 with a total of 5,472,893 shares traded.
Over the past week, the price has changed by +11.77%, over one month by +18.48%, over three months by -18.33% and over the past year by -32.05%.
Partly, yes. Based on ValueRay Fundamental Analyses, Brown-Forman (NYSE:BF-B) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.58 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BF-B as of March 2025 is 31.85. This means that BF-B is currently overvalued and has a potential downside of -13.76%.
Brown-Forman has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold BF-B.
- Strong Buy: 1
- Buy: 3
- Hold: 11
- Sell: 3
- Strong Sell: 1
According to ValueRays Forecast Model, BF-B Brown-Forman will be worth about 34.4 in March 2026. The stock is currently trading at 36.93. This means that the stock has a potential downside of -6.85%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 41.4 | 12.2% |
Analysts Target Price | 47.6 | 28.8% |
ValueRay Target Price | 34.4 | -6.9% |